Table 2.
Indicator of pregnancy | n | % | Indicator of malaria | n | % |
---|---|---|---|---|---|
Pregnant* (Trimester, gestation, HCG, risk group or vulnerable group with
reference to pregnancy) |
1,824 |
64.2 |
Malaria |
2,241 |
78.9 |
Placenta |
505 |
17.8 |
P. falciparum |
555 |
19.5 |
Congenital |
220 |
7.7 |
P. vivax |
42 |
1.5 |
Birth (birth weight, birth outcome, childbirth, stillbirth, abortion, delivery,
parturition, premature, preterm, newborn, neonatal, child-bearing) |
195 |
6.9 |
Other species |
47 |
1.7 |
Maternal |
183 |
6.4 |
Anti-malarial (either word or anti-malarial
drug) |
451 |
15.9 |
IPTp |
162 |
5.7 |
ITN or net |
82 |
2.9 |
Foetus/foetal (Embryo, developmental toxicity, offspring, reproductive
toxicity, teratogenic, in utero, trophoblast) |
149 |
5.2 |
Insecticide |
46 |
1.6 |
Antenatal/prenatal/perinatal/postpartum (puerperal, postnatal) |
120 |
4.2 |
Other (e.g. Anopheles gambiae, VAR2CSA,
haemozoin, malaria specific antibodies) |
15 |
0.5 |
Cord |
56 |
2.0 |
|
||
Gravid (primigravidae, multigravidae) |
47 |
1.7 |
|
|
|
CSA only |
24 |
0.8 |
|
|
|
Breast milk |
20 |
0.7 |
|
|
|
Diseases characteristic for pregnancy, e.g. pre-eclampsia, HELLP syndrome | 5 | 0.2 |
Abbreviations: CSA chondroitin sulphate A; HCG human chorionic gonadotropin (a hormone produced during pregnancy); IPTp intermittent preventive treatment in pregnancy; ITN insecticide treated nets.
*An item can have more than one key word related to pregnancy or malaria in the title.